ICMR warns against 'indiscriminate' use of plasma therapy

As per ICMR advisory, the potential recipients include patients in early stages of the viral disease, 3-7 days from the onset of symptoms, but not later than 10 days; and having no IgG antibody (which is the longer lasting antibody against Sars-Cov-2) against Covid-19 using appropriate confirmatory test.

from Hindustan Times - india https://ift.tt/38QqSh4
Share on Google Plus

About Md Asif Raza

0 comments:

Post a Comment